Axiora Medical
Axiora Medical
Standard & customized instruments engineered from premium medical alloys for optimal surgical navigation and implant placement.
The Barcelona metropolitan area has consolidated its status as Spain’s premier hub for biomedical innovation, healthcare logistics, and high-complexity surgical research. In Catalonia, the integration of public healthcare consortia (such as CatSalut) and internationally renowned private clinical chains has created a highly demanding procurement framework for joint reconstruction technologies. Orthopedic surgeons in Barcelona's leading institutions—including the Hospital Clínic de Barcelona, Hospital de la Santa Creu i Sant Pau, and Hospital Universitari Vall d'Hebron—demand implant solutions that optimize patient outcomes, reduce surgical duration, and lower postoperative revision rates.
From a commercial standpoint, distributors within the Catalonian and wider European markets are navigating a complex regulatory transition. The implementation of the European Union Medical Device Regulation (MDR 2017/745) has elevated the compliance threshold for Class III devices like Total Hip Replacements (THR) and Total Knee Replacements (TKR). Importers in Barcelona now prioritize working with manufacturing plants that possess comprehensive clinical data, absolute traceability from raw materials to final sterilization, and robust quality inspection regimes.
Establishing direct partnerships with advanced OEM/ODM manufacturers allows European medical device brands and hospital suppliers in Barcelona to offset rising procurement costs while guaranteeing 100% adherence to European Union quality directives.
The global orthopedic implant market is undergoing a structural transition driven by shifting demographic patterns and technological advancements. As populations age, the incidence of severe osteoarthritis, osteonecrosis, and post-traumatic arthritis increases. Concurrently, younger, more active patients are presenting with requirements for joint replacements, pushing the demand for implants that offer higher durability and biomimetic performance.
Transition from traditional Cobalt-Chromium alloys to titanium structures with plasma-sprayed Hydroxyapatite (HA) coatings. This promotes rapid osseointegration and prevents long-term implant loosening.
Increased utilization of Dual Mobility Cups in hip arthroplasty to minimize dislocation risks in high-risk patients, especially in complex revision surgeries performed across Spanish medical centers.
Widespread adoption of highly cross-linked polyethylene (UHMWPE) infused with Vitamin E, delivering high resistance to wear and oxidation, extending implant lifespans to over 20 years.
Axiora Medical Technology (China) Co., Ltd. is a leading professional manufacturer specializing in the research, development, precision production, and global supply of high-grade orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and sterile packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery. Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa.
| Specification Parameter | Industrial Capability Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand Positioning | Axiora High-Performance Orthopedic Solutions |
| Website | www.axioraortho.com |
| Established Year | 2017 |
| Factory Footprint | 18,600 m² state-of-the-art production complex |
| Annual Export Revenue | USD 26 Million |
| Export Track Record | 8 Years |
| Core Industry Experience | 15 Years of Precision Metallurgy & Machining |
| Quality Control Protocol | 100% Finished Product Inspection & Incoming Material Inspection |
| Testing Capabilities | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Dedicated Quality Staff | 48 Certified Quality Control Engineers |
| Core Business Models | Manufacturer & Exporter (OEM/ODM/OBM) |
| Primary Demographics | Europe, North America, Middle East, Southeast Asia, South America |
| Global Supply Network | 1,120 Distribution Partners & Healthcare Suppliers |
| Target Client Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Competence | Independent Product Development, Reverse Engineering, Custom OEM & ODM Solutions |
| Customization Options | Laser Etching, Private Labeling, Custom Sterile Packaging, Product Design, Custom Material Sourcing |
| R&D Velocity | 126 New Product Configurations Released Last Year |
| Engineering Capacity | 86 R&D Engineers specializing in Biomechanics and Metallurgy |
Our factory utilizes a fully integrated, modern manufacturing pipeline to ensure every implant and instrument meets Class III medical product guidelines. Below is the technical roadmap of our production floor:
For orthopedic supply chains in Barcelona, navigating international logistics demands absolute alignment on regional certifications, customs validation, and technical documentation. Axiora acts as more than a manufacturing vendor; we function as a strategic growth partner, integrating solutions directly into the importer's operating framework.
Our implants are built to accommodate standard clinical pathways across Spain, including Direct Anterior Approach (DAA) procedures that require slim femoral stems to minimize soft-tissue trauma. The modularity of our hip components enables orthopedists to address structural bone loss during revision arthroplasty, using cementless offset configurations and dual mobility designs to restore normal joint kinetics.
Get answers to technical, regulatory, and logistics questions concerning orthopedic implant supply for Spain and the European market.
Equip your clinical catalog with certified, high-performance hip and knee systems. Reach out to our design and sourcing engineers to discuss specifications, pricing, and regulatory timelines.
Get a Customized QuoteFull-range arthroplasty components manufactured under sterile conditions, fully compliant with clinical protocols in the Barcelona market.
